Phibro Animal Health’s Consensus Estimate Rises 7.6% While Shares Gain 24.6%
Phibro Animal Health has earned a top Zacks Rank #1 after its consensus earnings estimate rose 7.6% over 60 days. Its shares have climbed 24.6% in three months versus the S&P 500’s 3.9% gain, and it holds a Momentum Score of A.
1. Earnings Estimate Upgrades
Phibro Animal Health’s consensus earnings projection for the current fiscal year increased by 7.6% over the past 60 days, reflecting stronger-than-expected demand in its animal health and mineral nutrition segments. Upgrades were driven by improved sales forecasts and cost management initiatives within key markets.
2. Comparative Share Performance and Momentum
Over the past three months, Phibro’s shares have risen 24.6%, outpacing the S&P 500’s 3.9% gain. This performance has earned the company a Momentum Score of A, reflecting robust price momentum, trading volume trends, and positive analyst estimate revisions.